Danae Black holds a PhD in Epidemiology from the University of Washington, a MPH in Global Health Epidemiology from the George Washington University, and a BA in Neuroscience from Texas Christian University. During her master's level studies, she worked as an assistant study coordinator for the Kenya Medical Research Institute and Centers for Disease Control and Prevention conducting a diagnostic TB trial among children under five. Danae's interests include tuberculosis, global health and infectious disease epidemiology. Danae has experience as a research analyst for Truven Health Analytics, where she conducted health outcomes research projects for pharmaceutical customers. Her work with Truven's Life Sciences team primarily focused on utilization and cost outcomes among U.S. Medicare and Medicaid patient populations. During her time as a Senior Research Analyst at IBM, Danae provided analytic support to the Life Sciences Outcomes Research & Market Analytics business areas of Watson Health. She provided project support for pharmaceutical clients seeking statistical analyses for medications, devices, and procedures. She was also responsible for developing study protocols, file specifications, and data investigation for these research projects.
Danae is currently a Director of Biostatistics and Data Science at OMNY Health.